Market Segmentation by Drug Class, Route of Administration, and End-User
The Corneal Ulcer Treatment Market can be segmented based on drug class, route of administration, and end-user. Understanding these segments is crucial for identifying growth opportunities and tailoring product development strategies.
By drug class, antibiotics remain the cornerstone of treatment, particularly fluoroquinolones, due to their broad-spectrum activity. Antifungals such as natamycin and voriconazole address fungal infections, while antivirals like acyclovir are used for viral ulcers. Corticosteroids are prescribed in specific cases to control inflammation, although their use requires careful monitoring to avoid exacerbating infections.
In terms of route of administration, topical eye drops dominate because of their ease of use and rapid local effect. However, severe cases may require systemic therapy, such as oral or intravenous medications, especially when the infection threatens deeper ocular structures. Intracameral injections are reserved for resistant or advanced-stage ulcers.
When analyzed by end-user, hospitals and specialized ophthalmic clinics represent the largest market share, as they possess the necessary infrastructure for advanced diagnostics and surgical interventions. Retail pharmacies and e-pharmacies are important for follow-up medication supplies, with the latter gaining traction in urban areas due to convenience and growing digital adoption.